CSF alleviated gestational diabetes exacerbation and metabolic dysfunctions in mice by suppressing the TLR4/NF-κB pathway, as evidenced by the decrease in TLR4 and p-p65 [79]. The gene discussed is NFKB1; the disease is gestational diabetes.